Scopus BioPharma Inc. (SCPS)

[FACT-MASTER]

https://ih.advfn.com/stock-market/NASDAQ/scopus-biopharma-SCPS/stock-news/87982197/amended-annual-report-10-k-a

"The Nasdaq deficiency notification letters require the company to regain compliance with the Majority Independent Requirement and the Audit Committee and Compensation Committee Requirements in a timeframe specified by Nasdaq. As a result of the reconstitution of the Board and Audit Committee and Compensation Committee resulting from the resignations of two directors whose independence could not be assessed and the addition of Dr. Hofstein to the Board, the company believes, subject to a determination by Nasdaq, that it has regained compliance with the Audit Committee and Compensation Committee Requirements. As required by Nasdaq, the company intends to submit its plan for regaining compliance with the Majority Independent Requirement shortly."

Nice work SCPS mgmt., imo.

Next - Delaware Intervention Complaint case. ( if i'm not mistaken, coming up in June/22)